Cornelius, J. R., Soloff, P. H., Perel, J. M., et al (1993) Continuation pharmacotherapy of borderline personality disorder with haloperidol and phenelzine. American Journal of Psychiatry, 150, 1843–1848.
Cowdry, R. W. & Gardner, D. L. (1988) Pharmacotherapy of borderline personality disorder: alprazolam. carbamazepine, trifluoperazine and tranylcypromine. Archives of General Psychiatry, 45, 111–119.
De Girolamo, G. & Reich, J. H. (1993) Personality Disorders. Geneva: World Health Organization.
Deltito, J. A. & Stam, M. (1989) Psychopharmacological treatment of avoidant personality disorder. Comprehensive Psychiatry, 30, 498–504.
George, A. & Soloff, P. H. (1986) Schizotypal symptoms in patients with borderline personality disorders. American Journal of Psychiatry, 143, 212–215.
Goldberg, S. C., Shulz, S. C., Shulz, P. M., et al (1986) Borderline and schizotypal personality disorders treated with low dose thiothixene versus placebo. Archives of General Psychiatry, 43, 680–686.
Herbert, J. D., Hope, D. A. & Bellack, A. S. (1992) Validity of the distinction between generalized social phobia and avoidant personality disorder. Journal of Abnormal Psychology, 101, 332–339.
Klar, H. & Siever, L. J. (1984) The psychopharmacologic treatment of personality disorders. Psychiatric Clinics of North America, 7, 791–801.
Links, P. S., Steiner, M., Boiago, I., et al (1990) Lithium therapy for borderline patients: preliminary findings. Journal of Personality Disorders, 4, 173–181.
Merry, J., Reynolds, C. M., Bailey, J., et al (1976) Prophylactic treatment of alcoholism by lithium carbonate. Lancet, ii, 481–482.
Murphy, S. M. & Tyrer, P. (1991) A double-blind comparison of the effects of gradual withdrawal of lorazepam, diazepam and bromazepam in benzodiazepine dependence. British Journal of Psychiatry, 158, 511–516.
Reich, J. & Thompson, W. D. (1987) DSM–III personality disorder clusters in three generations. British Journal of Psychiatry, 150, 471–475.
Salzman, C., Wolfson, A. N., Schatzberg, A., et al (1995) Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder. Journal of Clinical Psychopharmacology, 15, 23–29.
Shawcross, C. R. & Tyrer, P. (1985) Influence of personality on response to monoamine oxidase inhibitors and tricyclic antidepressants. Journal of Psychiatric Research, 19, 557–562.
Shea, M. T., Pilkonis, P. A., Beckham, E., et al (1990) Personality disorders and treatment outcome in the NIMH treatment of depression collaborative research program. American Journal of Psychiatry, 147, 711–718.
Sheard, M. H., Marini, J. L., Bridges, C. I., et al (1976) The effect of lithium on impulsive aggressive behavior in man. American Journal of Psychiatry, 133, 1409–1413.
Soloff, P. H. (1994) Is there any drug treatment of choice for the borderline patient?
Acta Psychiatrica Scandinavica, 89 (suppl. 379), 50–55.
Soloff, P. H., George, A., Nathan, R. S., et al (1986) Progress in pharmacotherapy of personality disorders: a double blind study of amitriptyline, haloperidol and placebo. Archives of General Psychiatry, 43, 691–697.
Stein, G. S. (1992) Drug treatment of the personality disorders. British Journal of Psychiatry, 161, 167–184.
Tyrer, P. (1985) Neurosis divisible?
Lancet, i, 685–688.
Tyrer, P. & Johnson, T. (1996) Establishing the severity of personality disorder. American Journal of Psychiatry, 153, 1593–1597.
Tyrer, P., Owen, R. & Dawlings, S. (1983) Gradual withdrawal of diazepam after long-term therapy. Lancet, i, 1402–1406.
Tyrer, P., Sievewright, N., Ferguson, B., et al (1993) The Nottingham Study of Neurotic Disorder: effect of personality status on response to drug treatment, cognitive therapy and self-help over two years. British Journal of Psychiatry, 162, 219–226.
Tyrer, S. P., Walsh, A., Edwards, D. E., et al (1984) Factors associated with a good response to lithium in aggressive mentally handicapped subjects. Progress in Neuropsychopharmacology and Biological Psychiatry, 8, 751–755.